APOE and Cognitive impairment: Studies of cortical Aβ on PET imaging consistently reported that higher BMI was associated with lower Aβ burden in older cognitively normal individuals (>60 years), ApoE4 carriers with either mild or no cognitive impairments, and clinically normal older people (age 62–90 years) (47–49).